Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on February 9, 2009

Hypertension. 2009
Published online before print February 9, 2009, doi: 10.1161/HYPERTENSIONAHA.108.120816
A more recent version of this article appeared on March 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
53/3/539    most recent
HYPERTENSIONAHA.108.120816v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cai, J.
Right arrow Articles by Yang, X.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cai, J.
Right arrow Articles by Yang, X.-C.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Cardio-renal physiology/pathophysiology
Right arrow Remodeling
Right arrow Gene expression
Right arrow Hypertension - basic studies
Right arrow Hypertrophy
Right arrow Physiological and pathological control of gene expression
Right arrowRelated Article

Submitted on July 31, 2008
Revised on August 24, 2008

Targeted Expression of Receptor-Associated Late Transducer Inhibits Maladaptive Hypertrophy via Blocking Epidermal Growth Factor Receptor Signaling

Jun Cai; Fang-Fang Yi; Long Yang; Di-Fei Shen; Qinling Yang; Ankang Li; Asish K. Ghosh; Zhou-Yan Bian; Ling Yan; Qi-Zhu Tang; Hongliang Li*; and Xin-Chun Yang*

From the Cardiovascular Research Center (J.C.), Massachusetts General Hospital, Harvard Medical School, Charlestown, Mass; Department of Cardiology (J.C., F.F.Y., L.Yang, X.-C.Y.), Beijing Chaoyang Hospital, Capital Medical University, Beijing, China; Cardiovascular Research Institute of Wuhan University (D.-F.S., Z.-Y.B., L.Yan, Q.-Z.T., H.L.), Wuhan, China; Department of Cardiology (D.-F.S., Z.-Y.B., L.Yan, Q.-Z.T., H.L.), Renmin Hospital of Wuhan University, Wuhan, China; Department of Nutrition Sciences (Q.Y.), University of Alabama at Birmingham; Gene Expression Laboratory (A.L.), The Salk Institute for Biological Studies, La Jolla, Calif; and Division of Rheumatology (A.K.G.), Northwestern University Feinberg School of Medicine, Chicago, Ill.

* To whom correspondence should be addressed. E-mail: lihl{at}whu.edu.cn or yangxc{at}medmail.com.cn.

Abstract—Receptor-associated late transducer (RALT) is a feedback inhibitor of epidermal growth factor receptor signaling. RALT has been shown previously to be induced in the ischemic heart and to promote cardiomyocyte apoptosis in vitro. However, the role of RALT in cardiac hypertrophy remains unclear. We hypothesized that forced expression of RALT in the murine heart would protect the heart against cardiac hypertrophy in vivo. We investigated the effect of cardiac overexpression of rat RALT on cardiac hypertrophy induced by angiotensin II and isoproterenol in RALT transgenic mice and wild-type littermates. The extent of cardiac hypertrophy was assessed by 2D and M-mode echocardiography as well as by molecular and pathological analyses of cardiac samples. Constitutive expression of rat RALT in cardiac myocytes of murine heart attenuated both hypertrophic and inflammatory responses and preserved cardiac function. These beneficial effects were associated with the attenuation of the epidermal growth factor receptor–dependent cascade that was triggered by angiotensin II and isoproterenol stimulation. Additional evidence demonstrated that RALT expression blocked fibrosis in vivo and collagen synthesis in vitro. Therefore, cardiac overexpression of RALT improves cardiac function and inhibits maladaptive hypertrophy, inflammation, and fibrosis through attenuating epidermal growth factor receptor–dependent signaling.


Key words: RALT • EGFR • ERK1/2 • cardiac hypertrophy • heart failure • fibrosis


Related Article:

RALT Specifically Halts Maladaptive Cardiac Hypertrophy: A New Kid on the Block
Martin W. Bergmann and Laura Zelarayan
Hypertension 2009 53: 454-455. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
HypertensionHome page
M. W. Bergmann and L. Zelarayan
RALT Specifically Halts Maladaptive Cardiac Hypertrophy: A New Kid on the Block
Hypertension, March 1, 2009; 53(3): 454 - 455.
[Full Text] [PDF]